IL28B-CC GENOTYPE-RELATED GENE EXPRESSION DURING TREATMENT OF CHRONIC HEPATITIS C (CH-C) WITH PEGYLATED INTERFERON-ALFA (PEG-IFN) AND RIBAVIRIN (RBV): POTENTIAL MECHANISMS FOR SUSTAINED VIROLOGIC RESPONSE (SVR)

被引：2
|
作者：
Younossi, Z. M. [1 ,2 ,3 ]
Estep, J. M. [3 ]
Birerdinc, A. [1 ,2 ]
Stepanova, M. [1 ,3 ]
Baranova, A. [1 ,2 ]
Younossi, I. [1 ]
Afendy, A. [1 ,3 ]
机构：
[1] Inova Hlth Syst, Betty & Guy Beatty Ctr Integrated Res, Falls Church, VA USA
[2] George Mason Univ, Mol & Microbiol Dept, Ctr Study Genom Liver Dis, Fairfax, VA 22030 USA
[3] Inova Fairfax Hosp, Ctr Liver Dis, Falls Church, VA USA
来源：
JOURNAL OF HEPATOLOGY | 2011年 / 54卷
关键词：
D O I：
10.1016/S0168-8278(11)61354-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1352
引用
收藏
页码：S534 / S534
页数：1
相关论文
共 50 条
  • [1] AKT ACTIVATION IS ASSOCIATED WITH SUSTAINED VIROLOGIC RESPONSE (SVR) AFTER TREATMENT WITH PEGYLATED INTERFERON-ALFA AND RIBAVIRIN (PEG-IFN plus RBV) IN PATIENTS WITH CHRONIC HEPATITIS C (CH-C)
    Birerdinc, Aybike
    Stepanova, Maria
    Limongi, Dolores
    Afendy, Arian
    Pierobon, Mariaelena
    Younossi, Issah
    Liotta, Lance
    Baranova, Ancha
    Petricoin, Emanuel F.
    Younossi, Zobair M.
    HEPATOLOGY, 2010, 52 (04) : 728A - 728A
  • [2] PROTEIN PATHWAY BIOMARKERS PREDICTING SUSTAINED VIROLOGIC RESPONSE (SVR)TO PEGYLATED INTERFERON (PEG-IFN) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C (CH-C)
    Younossi, Z.
    Limongi, D.
    Stepanova, M.
    Pierobon, M.
    Afendy, A.
    Liotta, L.
    Petricoin, E.
    JOURNAL OF HEPATOLOGY, 2010, 52 : S420 - S420
  • [3] HEPATIC STEATOSIS AND SERUM GLUCOSE NEGATIVELY AFFECT SUSTAINED VIROLOGIC RESPONSE (SVR) AFTER TREATMENT WITH PEGYLATED INTERFERON ALFA AND RIBAVIRIN (PEG-IFN/RBV) IN CHRONIC HEPATITIS C (CH-C) PATIENTS CARRYING IL28B NON-"CC" GENOTYPE
    Guragain, Richesh
    Estep, J. Michael
    Afendy, Arian
    Stepanova, Maria
    Chandhoke, Vikas
    Baranova, Ancha
    Younossi, Zobair M.
    HEPATOLOGY, 2011, 54 : 1142A - 1142A
  • [4] Protein Pathway Biomarkers Predicting Sustained Virologic Response (SVR) to Pegylated Interferon (PEG-IFN) and Ribavirin (RBV) in Treatment-Naive Genotype 1 Patients With Chronic Hepatitis C (Ch-C)
    Limongi, Dolores
    Stepanova, Maria
    Afendy, Arian
    Pierobon, Mariaelena
    Agrawal, Ritambhara
    Liotta, Lance
    Petricoin, Emanuel
    Younossi, Zobair M.
    GASTROENTEROLOGY, 2010, 138 (05) : S783 - S783
  • [5] Gene expression profiles of patients with chronic hepatitis C (CH-C) treated with pegylated interferon alfa-2b and ribavirin (PEG-IFN/RBV)
    Younossi, ZM
    Chan, J
    Schlauch, K
    Assmann, J
    Santini, C
    Ong, J
    Martin, L
    Gramlich, T
    McAllister, L
    Chang, SY
    GASTROENTEROLOGY, 2004, 126 (04) : A719 - A720
  • [6] ASSOCIATION OF ITPA SNP WITH THE GENE EXPRESSION PROFILE OF CHRONIC HEPATITIS C (CH-C) PATIENTS WHO DEVELOP ANEMIA DURING TREATMENT WITH PEGYLATED INTERFERON ALFA AND RIBAVIRIN (PEG-IFN/RBV)
    Estep, J. Michael
    Birerdinc, Aybike
    Afendy, Arian
    Stepanova, Maria
    Baranova, Ancha
    Younossi, Zobair M.
    HEPATOLOGY, 2011, 54 : 1177A - 1177A
  • [7] Darbepoetin alfa (DA) for ribavirin-induced anemia in patients with chronic hepatitis C (CH-C) treated with pegylated interferon and ribavirin (peg-ifn/rbv): A preliminary analysis
    Younossi, ZM
    Ong, JP
    Collantes, R
    Assmann, JS
    Sjogren, R
    Sjogren, M
    Farmer, D
    Gujral, H
    Martin, L
    GASTROENTEROLOGY, 2004, 126 (04) : A666 - A666
  • [8] PREDICTORS OF SUSTAINED VIROLOGICAL RESPONSE (SVR) TO PEGYLATED INTERFERON ALPHA (PEG-IFN alpha) AND RIBAVIRIN (RBV) IN PATIENTS WITH CHRONIC HEPATITIS C INFECTED WITH GENOTYPE 1
    Antonov, Krasimir
    Jelev, Deian
    Ivanova, A.
    Krastev, Zahariy
    JOURNAL OF IMAB, 2011, 17 (01): : 197 - 199
  • [9] Protein Pathway Activation Associated with Sustained Virologic Response in Patients with Chronic Hepatitis C Treated with Pegylated Interferon (PEG-IFN) and Ribavirin (RBV)
    Younossi, Zobair M.
    Limongi, Dolores
    Stepanova, Maria
    Pierobon, Mariaelena
    Afendy, Arian
    Mehta, Rohini
    Baranova, Ancha
    Liotta, Lance
    Petricoin, Emanuel
    JOURNAL OF PROTEOME RESEARCH, 2011, 10 (02) : 774 - 779
  • [10] A panel of gene expression biomarkers predicting sustained virologic response (SVR) in chronic hepatitis C patients (CH-C) treated with pegylated interferon alpha and ribavirin
    Younossi, Z. M.
    Baranova, A.
    Stepanova, M.
    Afendy, A.
    Wheeler, A.
    Hossain, N.
    Bakshi, A.
    Santini, C. D.
    Sigua, C. L.
    Chan, J.
    Iverson, A. A.
    Chang, S. P.
    JOURNAL OF HEPATOLOGY, 2008, 48 : S286 - S286
12345